Breaking News Instant updates and real-time market news.

ACAD

Acadia

$13.90

-1.33 (-8.73%)

07:24
08/07/18
08/07
07:24
08/07/18
07:24

Acadia initiated with a Hold at Stifel

Stifel analyst Paul Matteis initiated coverage of Acadia with a Hold rating and a $17 price target, stating that he believes a company update on the ongoing pimavanserin FDA safety review in the second of this year or early 2019 will remove an overhang. However, his estimates are "materially below consensus" in 2019 and he expect pimavanserin to "churn its way" to $594M in PDP revenue by 2022, which is also materially below sell-side expectations.

  • 08

    Aug

  • 30

    Aug

  • 31

    Aug

ACAD Acadia
$13.90

-1.33 (-8.73%)

04/26/18
JPMS
04/26/18
NO CHANGE
JPMS
Overweight
JPMorgan still sees low risk of Acadia drug being pulled from market
JPMorgan analyst Cory Kasimov continues to see a low, "but not zero," risk of Acadia Pharmaceuticals' Nuplazid being pulled from the market. Yesterday's CNN report is "mostly noise" and "nothing new," Kasimov told investors last night in a research note. The analyst, however, says he can appreciate the impact of the FDA Commissioner indicating he would "take another look" at the drug's safety profile. Kasimov predicates his views on the formal FDA review and the agency's initial statement that Nuplazid's safety profile is consistent with the label, as well as additional commentary he received yesterday from management. The analyst views yesterday's pullback in shares of Acadia as "fundamentally unjustified based on current information." He kept an Overweight rating on the stock. Shares of Acadia are up 5% to $15.95 in early trading.
08/06/18
PIPR
08/06/18
DOWNGRADE
Target $19
PIPR
Neutral
Acadia downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Danielle Brill downgraded Acadia Pharmaceuticals to Neutral and cut her firm's price target for the shares to $19 from $61 after taking over coverage of the name. The stock closed Friday down 27c to $15.22. The recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future, Brill tells investors in a research note. Further, the analyst does not have a high level of conviction for positive data from Acadia's near-term catalysts, namely the Phase 2 major depressive disorder data in September and the Phase 2 negative schizophrenia symptoms readout in the first half of 2019.
08/06/18
08/06/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Equal Weight from Overweight at Barclays with analyst Blayne Curtis saying he believes upside in the shares will be challenging until the company's margins bottom. 2. Immune Pharmaceuticals (IMNP) downgraded to Hold from Buy at Maxim with analyst Jason McCarthy citing the company's delisting from Nasdaq and evaluation of strategic options as it seeks to resolve its financing overhang. 3. Flowers Foods (FLO) downgraded to Equal Weight from Overweight at Consumer Edge. 4. CommScope (COMM) downgraded to Hold from Buy at Jefferies with analyst George Notter saying after "further reflection" from the earnings call and conversations with industry contacts, he believes CommScope's Mobility division performance will not improve this year or next. 5. Acadia (ACAD) downgraded to Neutral from Overweight at Piper Jaffray with analyst Danielle Brill saying the recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/06/18
08/06/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. INTERCEPT DOUBLE UPGRADED AT GOLDMAN: Goldman Sachs analyst Salveen Richter double upgraded Intercept Pharmaceuticals (ICPT) to Buy from Sell and raised his price target for the shares to $157 from $46. The analyst said Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. Intercept should benefit from Ocaliva's global first-mover advantage in NASH, Richter said. In late morning trading, Intercept shares are up 12%. BUCKINGHAM UPGRADES SQUARE TO BUY: Buckingham upgraded Square (SQ) to Buy from Neutral and raised its price target to $85 from $65. Analyst Chris Brendler said the strong Q2 results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better then expected core revenue growth into 2020. Brendler said long-run adjusted EBITDA margins of 40%-50% justify a higher valuation. PIPER CUTS ACADIA TO NEUTRAL: Piper Jaffray analyst Danielle Brill downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Overweight and cut her firm's price target on shares to $19 from $61 after taking over coverage of the name. The recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future, Brill said. Further, the analyst does not have a high level of conviction for positive data from Acadia's near-term catalysts, namely the Phase 2 major depressive disorder data in September and the Phase 2 negative schizophrenia symptoms readout in the first half of 2019. BARCLAYS CUTS INTEL TO EQUAL WEIGHT: Barclays analyst Blayne Curtis downgraded Intel (INTC) to Equal Weight from Overweight and cut his price target for the shares to $53 from $62. The analyst believes upside in the shares will be challenging until the company's margins bottom. JEFFERIES SAYS OHIO INCIDENT NOT A RISK TO CHIPOTLE TRAFFIC: After analyzing digital engagement with the brand from last week and compared to the Virginia incident last July, Jefferies analyst Andy Barish does not believe the illnesses at the Ohio restaurant put Chipotle Mexican Grill's (CMG) traffic trends at risk. The analyst believes Chipotle's procedures were followed in Ohio, the number of cases was not substantiated, and the company did a better job controlling the narrative and taking action. Barish kept a Buy rating on Chipotle shares with a $550 price target.

TODAY'S FREE FLY STORIES

TGT

Target

$70.14

-6.99 (-9.06%)

, KSS

Kohl's

$65.26

-5.49 (-7.76%)

11:21
11/20/18
11/20
11:21
11/20/18
11:21
OnTheFly
Target, Kohl’s slide after quarterly results amid concerns about holiday season »

Shares of Target (TGT)…

TGT

Target

$70.14

-6.99 (-9.06%)

KSS

Kohl's

$65.26

-5.49 (-7.76%)

BBY

Best Buy

$64.90

2.71 (4.36%)

AMZN

Amazon.com

$1,519.79

8.12 (0.54%)

WMT

Walmart

$94.20

-2.6 (-2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 28

    Nov

  • 04

    Dec

  • 05

    Dec

  • 03

    Mar

CVE

Cenovus Energy

$7.64

-0.39 (-4.86%)

11:20
11/20/18
11/20
11:20
11/20/18
11:20
Options
Call spreads in Cenovus Energy as shares fall 4.6% »

Call spreads in Cenovus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/20/18
11/20
11:17
11/20/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$88.76

-2.58 (-2.82%)

11:16
11/20/18
11/20
11:16
11/20/18
11:16
Recommendations
Lowe's analyst commentary  »

Investors should step…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/20/18
11/20
11:16
11/20/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
11/20/18
11/20
11:15
11/20/18
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

11:15
11/20/18
11/20
11:15
11/20/18
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

TC

TuanChe

$0.00

(0.00%)

11:14
11/20/18
11/20
11:14
11/20/18
11:14
Syndicate
TuanChe opens at $7.50, IPO priced at $7.80 per share »

TuanChe (TC) priced 2.6M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BDIMF

Black Diamond Group

$0.00

(0.00%)

11:12
11/20/18
11/20
11:12
11/20/18
11:12
Conference/Events
Black Diamond Group management to meet with Raymond James »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BBY

Best Buy

$64.08

1.89 (3.04%)

11:10
11/20/18
11/20
11:10
11/20/18
11:10
Options
Best Buy puts active as shares see relative strength »

Best Buy puts active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 05

    Dec

AAPL

Apple

$179.47

-6.33 (-3.41%)

, AMZN

Amazon.com

$1,505.00

-6.67 (-0.44%)

11:06
11/20/18
11/20
11:06
11/20/18
11:06
Hot Stocks
White House asks for comment on possible emerging technology export restrictions »

In an advance notice of…

AAPL

Apple

$179.47

-6.33 (-3.41%)

AMZN

Amazon.com

$1,505.00

-6.67 (-0.44%)

GOOGL

Alphabet Class A

$1,027.00

0.77 (0.08%)

GOOG

Alphabet

$1,018.84

-0.16 (-0.02%)

IBM

IBM

$118.62

-1.75 (-1.45%)

FB

Facebook

$133.10

1.48 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

  • 04

    Dec

  • 04

    Dec

  • 03

    Mar

AMZN

Amazon.com

$1,501.81

-9.86 (-0.65%)

11:04
11/20/18
11/20
11:04
11/20/18
11:04
Technical Analysis
Technical Take: Amazon.com hits highs of the session »

The shares of Amazon.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

OKTA

Okta

$47.47

-1.17 (-2.41%)

11:03
11/20/18
11/20
11:03
11/20/18
11:03
Hot Stocks
Okta continues expansion of API gateway partner ecosystem »

Okta announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Jan

AJG

Arthur J. Gallagher

$77.73

-0.6 (-0.77%)

11:02
11/20/18
11/20
11:02
11/20/18
11:02
Hot Stocks
Arthur J. Gallagher acquires JP Tech Insurance Services, terms not disclosed »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNR

Denbury Resources

$2.29

-0.155 (-6.34%)

11:00
11/20/18
11/20
11:00
11/20/18
11:00
Options
2-strike put buyers in Denbury Resources as shares drop 9.3% »

2-strike put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
11/20/18
11/20
11:00
11/20/18
11:00
General news
Atlanta Fed's Q4 GDPNow estimate was cut to 2.5% »

Atlanta Fed's Q4…

DB

Deutsche Bank

$9.38

-0.39 (-3.99%)

, DNSKY

Danske Bank

$0.00

(0.00%)

10:56
11/20/18
11/20
10:56
11/20/18
10:56
Periodicals
Deutsche finds $150B of suspicious flows tied to Danske, WSJ reports »

Deutsche Bank's (DB)…

DB

Deutsche Bank

$9.38

-0.39 (-3.99%)

DNSKY

Danske Bank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NURO

NeuroMetrix

$0.98

-0.02 (-2.00%)

10:53
11/20/18
11/20
10:53
11/20/18
10:53
Hot Stocks
NeuroMetrix issued new U.S. patent for Quell wearable technology »

NeuroMetrix announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

X

U.S. Steel

$26.42

-0.86 (-3.15%)

10:50
11/20/18
11/20
10:50
11/20/18
10:50
Options
US Steel sees put buying as shares drop 4.4% »

US Steel sees put buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$5.98

-0.075 (-1.24%)

10:47
11/20/18
11/20
10:47
11/20/18
10:47
Periodicals
Snap soon to debut new, higher-priced Spectacles with two cameras, Cheddar says »

Snap is looking to debut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

TLSA

Tiziana Therapeutics

$0.00

(0.00%)

10:45
11/20/18
11/20
10:45
11/20/18
10:45
Syndicate
Tiziana Therapeutics opens at $10.50, IPO priced at $9.90 »

Tiziana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BE

Bloom Energy

$14.00

-0.5 (-3.45%)

10:45
11/20/18
11/20
10:45
11/20/18
10:45
Conference/Events
Bloom Energy has a conference call hosted by JPMorgan »

JPMorgan Analyst Coster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 05

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$264.96

-4.32 (-1.60%)

10:42
11/20/18
11/20
10:42
11/20/18
10:42
Technical Analysis
Technical Take: SPDR S&P 500 ETF breaks back above $265 »

The SPDR S&P 500 ETF…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$264.96

-4.32 (-1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$42.91

-1.51 (-3.40%)

10:40
11/20/18
11/20
10:40
11/20/18
10:40
Options
Put spreads in Morgan Stanley weekly options as shares fall to 52-week lows »

Put spreads in Morgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,478.00

-33.67 (-2.23%)

10:38
11/20/18
11/20
10:38
11/20/18
10:38
Technical Analysis
Technical Take: Amazon.com breaks back above $1500 »

The stock saw a deep low…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.